Dimetapp hasn’t been taken off the market. It’s just that the FDA warned that inexact dosing could lead to an overdose in children; GSK has not reported any adverse effects so far.
The recalled lots of Robitussin and Dimetapp were distributed nationwide between Feb. 5 and June 3 and carry the GSK and Pfizer brand names on their labels.
Related posts:
The content is intended to augment, not replace, information provided by your clinician. It is not intended nor implied to be a substitute for professional medical advice. Reading this information does not create or replace a doctor-patient relationship or consultation. If required, please contact your doctor or other health care provider to assist you to interpret any of this information, or in applying the information to your individual needs.